Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06572930 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

Study acronym: FSH
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 1, 2025 to Dec 1, 2026v5
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 1, 2024 to Dec 16, 2024
    • Site details revised
    v3
  4. Start date: Aug 25, 2024 to Dec 1, 2024
    • Primary completion date: Sep 1, 2025 to Dec 1, 2025
    • Study completion date: Oct 1, 2025 to Dec 1, 2025
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study examines if monitoring serum Follicle Stimulation Hormone (FSH) levels can predict oocyte yield and progesterone levels, considering factors like age, baseline FSH, Antral Mullerian Hormone (AMH), antral follicle count, body weight, kidney function, and urinary FSH. The aim is to find a minimum FSH level that ensures optimal ovarian response and enables tailored FSH dosages for better outcomes.
Trial Details
NCT Number NCT06572930
Lead Sponsor ART Fertility Clinics LLC
Conditions
(from sponsor)		 Ovarian Stimulation
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov